News Archive

Primary results of the INSEMA (Intergroup-Sentinel-Mamma) trial were presented at the 2024 San Antonio Breast Cancer Symposium and simultaneously published online in the NEJM on December 12, 2024. The authors concluded that axillary sentinel lymph node surgery can be safely omitted in patients with clinically node-negative early breast cancer undergoing upfront breast-conserving surgery and whole breast radiation (breast-conserving therapy).

The Society’s Call for Volunteers is now open! We are excited to offer opportunities on 18 committees, each with a unique and specialized focus.

ASBrS President Dr. Judy C. Boughey expresses warm holiday wishes to our community of breast surgeons.

The "Risk Assessment Module Tutorial" provides a guide to breast cancer risk assessment using various models, including the Tyrer Cuzick/IBIS, Gail, and ASK2ME.